Entyvio subkutan 108 mg, Injektionslösung in einem Fertigpen

7680675340019 CH-67534 Injektionslösung in einem Fertigpen
Entyvio subkutan 108 mg, Injektionslösung in einem Fertigpen
Entyvio subkutan 108 mg, Injektionslösung in einem Fertigpen
1 / 2
google

Article details

Package size
1
Selling units
1
Measure
Injektor(en), vorgefüllt/Pen
Galenic form
Injektionslösung in einem Fertigpen
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
23/08/2024
Patient information leaflet
Français
23/08/2024
Patient information leaflet
Italien
23/08/2024

Detailed composition

Substance Quantity Type Category
(N/A)
108.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
1.11 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 608.35
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/03/2021

Authorization holder

Takeda Pharma AG

8152 Opfikon

Authorization information

Swissmedic authorization number
67534
Drug name
Entyvio subkutan, Injektionslösung in einem Fertigpen
Galenic form
INLFP
ATC Code
L04AG05
Authorization status
Z
Dispensing category
A
First authorization
16/10/2020
Authorization expiration date
31/12/9999
IT Number
07.15.0.
Domain
Human medicine
Field of application
Colitis ulcerosa, Morbus Crohn

Package details

Description (FR)
ENTYVIO sous-cutanée 108 mg/0.68ml stylo prérempli
Description (DE)
ENTYVIO subkutan 108 mg/0.68ml Fertigpen
Market launch
16/10/2020
Narcotic (BTM)
No